These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25784542)

  • 1. SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.
    Koo YD; Choi JW; Kim M; Chae S; Ahn BY; Kim M; Oh BC; Hwang D; Seol JH; Kim YB; Park YJ; Chung SS; Park KS
    Diabetes; 2015 Jul; 64(7):2420-31. PubMed ID: 25784542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle.
    Koo YD; Lee JS; Lee SA; Quaresma PGF; Bhat R; Haynes WG; Park YJ; Kim YB; Chung SS; Park KS
    Metabolism; 2019 Jun; 95():27-35. PubMed ID: 30902749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SUMO-Specific Protease 2 in Leptin-Induced Fatty Acid Metabolism in White Adipocytes.
    Kim PC; Lee JS; Chung SS; Park KS
    Diabetes Metab J; 2023 May; 47(3):382-393. PubMed ID: 36872063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes.
    Chung SS; Ahn BY; Kim M; Kho JH; Jung HS; Park KS
    Biochem J; 2011 Jan; 433(1):155-61. PubMed ID: 20950277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Essential Role of the N-Terminal Region of ACSL1 in Linking Free Fatty Acids to Mitochondrial β-Oxidation in C2C12 Myotubes.
    Nan J; Lee JS; Lee SA; Lee DS; Park KS; Chung SS
    Mol Cells; 2021 Sep; 44(9):637-646. PubMed ID: 34511469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
    Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
    J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells.
    Djouadi F; Aubey F; Schlemmer D; Bastin J
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1791-7. PubMed ID: 15613406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial fat oxidation is essential for lipid-induced inflammation in skeletal muscle in mice.
    Warfel JD; Bermudez EM; Mendoza TM; Ghosh S; Zhang J; Elks CM; Mynatt R; Vandanmagsar B
    Sci Rep; 2016 Nov; 6():37941. PubMed ID: 27892502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscle.
    Hu S; Yao J; Howe AA; Menke BM; Sivitz WI; Spector AA; Norris AW
    Mol Endocrinol; 2012 Jun; 26(6):977-88. PubMed ID: 22474127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
    Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
    Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Long-Chain Acyl-CoA Synthetase 5 Increases Fatty Acid Oxidation and Free Radical Formation While Attenuating Insulin Signaling in Primary Human Skeletal Myotubes.
    Kwak HB; Woodlief TL; Green TD; Cox JH; Hickner RC; Neufer PD; Cortright RN
    Int J Environ Res Public Health; 2019 Mar; 16(7):. PubMed ID: 30935113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
    Jové M; Laguna JC; Vázquez-Carrera M
    Biochim Biophys Acta; 2005 May; 1734(1):52-61. PubMed ID: 15866483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor B inhibits lipid accumulation in C2C12 myotubes incubated with fatty acids.
    Li LJ; Ma J; Li SB; Chen X; Zhang J
    Growth Factors; 2019 Apr; 37(1-2):76-84. PubMed ID: 31215273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
    Zhao L; Pascual F; Bacudio L; Suchanek AL; Young PA; Li LO; Martin SA; Camporez JP; Perry RJ; Shulman GI; Klett EL; Coleman RA
    J Biol Chem; 2019 May; 294(22):8819-8833. PubMed ID: 30975900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new AMPK activator, GSK773, corrects fatty acid oxidation and differentiation defect in CPT2-deficient myotubes.
    Boufroura FZ; Le Bachelier C; Tomkiewicz-Raulet C; Schlemmer D; Benoist JF; Grondin P; Lamotte Y; Mirguet O; Mouillet-Richard S; Bastin J; Djouadi F
    Hum Mol Genet; 2018 Oct; 27(19):3417-3433. PubMed ID: 30007356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.